These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 38307459

  • 1. Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation.
    Mihailescu DV, Hoscheit C, Fogelfeld L.
    Endocr Pract; 2024 Apr; 30(4):333-339. PubMed ID: 38307459
    [Abstract] [Full Text] [Related]

  • 2. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T.
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [Abstract] [Full Text] [Related]

  • 3. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK, Larsen PR.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [Abstract] [Full Text] [Related]

  • 5. Identification of patients with Graves' disease who benefit from high-dose radioactive iodine therapy.
    Watanabe S, Okamoto S, Akikawa K, Miyamoto N, Okamura-Kawasaki M, Uchiyama Y, Takenaka J, Toyonaga T, Hirata K, Kudo K.
    Ann Nucl Med; 2022 Nov; 36(11):923-930. PubMed ID: 35972673
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radioiodine treatment of Graves' disease - dose/response analysis.
    Cepková J, Horáček J, Vižďa J, Doležal J.
    Acta Medica (Hradec Kralove); 2014 Nov; 57(2):49-55. PubMed ID: 25257150
    [Abstract] [Full Text] [Related]

  • 10. Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.
    Kanokwongnuwat W, Penpong N.
    BMC Endocr Disord; 2024 Apr 25; 24(1):54. PubMed ID: 38664774
    [Abstract] [Full Text] [Related]

  • 11. Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.
    Côté-Bigras S, Tran V, Turcotte S, Rola-Pleszczynski M, Verreault J, Rottembourg D.
    Endocrine; 2016 Jun 25; 52(3):587-96. PubMed ID: 26701678
    [Abstract] [Full Text] [Related]

  • 12. Methimazole discontinuation before radioiodine therapy in patients with Graves' disease.
    Zakavi SR, Khazaei G, Sadeghi R, Ayati N, Davachi B, Bonakdaran S, Jabbari Nooghabi M, Moosavi Z.
    Nucl Med Commun; 2015 Dec 25; 36(12):1202-7. PubMed ID: 26426965
    [Abstract] [Full Text] [Related]

  • 13. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome.
    Murakami Y, Takamatsu J, Sakane S, Kuma K, Ohsawa N.
    J Clin Endocrinol Metab; 1996 Sep 25; 81(9):3257-60. PubMed ID: 8784079
    [Abstract] [Full Text] [Related]

  • 14. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F, Giovannetti C, Fessehatsion R, Tanda ML, Campomori A, Compri E, Rossi G, Ceccarelli C, Vitti P, Pinchera A, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2010 Jan 25; 95(1):201-8. PubMed ID: 19906789
    [Abstract] [Full Text] [Related]

  • 15. Predictors of Prolonged Euthyroidism After Radioactive Iodine Treatment for Graves' Disease: A Pilot Study.
    Lu JY, Chen KH, Shih SR, Wen FY, Wu WC, Chen TC, Hu FC.
    Endocr Pract; 2023 Feb 25; 29(2):89-96. PubMed ID: 36396015
    [Abstract] [Full Text] [Related]

  • 16. The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial.
    Braga M, Walpert N, Burch HB, Solomon BL, Cooper DS.
    Thyroid; 2002 Feb 25; 12(2):135-9. PubMed ID: 11916282
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
    Martin NM, Patel M, Nijher GM, Misra S, Murphy E, Meeran K.
    Clin Endocrinol (Oxf); 2012 Oct 25; 77(4):621-7. PubMed ID: 22443227
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlation between thyroid volume and humoral thyroid autoimmunity after radioiodine therapy in Graves' disease.
    Sawicka N, Sowiński J.
    Endokrynol Pol; 2012 Oct 25; 63(1):10-3. PubMed ID: 22378091
    [Abstract] [Full Text] [Related]

  • 20. Increased Risk of Radioiodine Treatment Failure Associated with Graves Disease Refractory to Methimazole.
    Kwak JJ, Altoos R, Jensen A, Altoos B, McDermott MT.
    Endocr Pract; 2020 Nov 25; 26(11):1312-1319. PubMed ID: 33471662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.